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Considering the reported activity of carvone in the literature, this study aimed to evaluate the antimicrobial, 
cytotoxic and chemopreventive activities of (+)- and (-)-carvone, (+)- and (-)- hydroxydihydrocarvone 
and α,β-epoxycarvone. (+)-Hydroxydihydrocarvone (HC+), (-)-hydroxydihydrocarvone (HC-) and α,β-
epoxycarvone (EP) were obtained by synthesis using (+)-carvone (C+) or (-)-carvone (C-) as precursors. 
The antifungal activity (MIC and MFC) were evaluated against Candida parapsilosis, C. tropicalis, 
C. krusei and C. albicans and the antibacterial activity (MIC and MBC) against Escherichia coli and 
Staphylococcus aureus. The cytotoxicity assays were performed with human cancer cell lines HepG-
2 and SiHa and the normal strain MRC-5 through sulphorrodamine B assay. Chemoprevention was 
evaluated through quinone reductase assay. Our results showed no cytotoxicity on tumor and normal 
cell lines and no induction of the quinone reductase enzyme. C- and HC- presented activity against E. 
coli. All compounds presented weak antifungal activity against C. tropicalis and C. parapsilosis. EP 
and C+ showed moderate activity against C. krusei. Results suggest the potential use of carvones and 
its derivatives as antifungal agents against Candida yeasts. The absence of cytotoxicity in cell lines 
indicates safety in the use of these compounds.
Keywords: Carvone/antimicrobial activity. Carvone/antifungal activity. Carvone /cytotoxicity. Carvone/
chemoprevention. 
INTRODUCTION
Natural products diversity is an important source in 
the search for bioactive compounds. Plants have a wide 
range of secondary metabolites that are important for the 
discovery of drugs for various diseases such as cancer 
and infections by microorganisms. Essential oils are 
generally a mixture of secondary metabolites including 
terpenes and phenolic compounds, mainly monoterpenes, 
sesquiterpenes, phenylpropanoids and other low molecular 
weight volatile compounds. Essential oils are responsible 
for the characteristic odor of aromatic plants which is 
important for attracting pollinators and seed dispersers, 
moreover, it acts as a defense mechanism against predators 
and diseases. Many of them present pharmacological 
activity and may be used therapeutically (De Sousa, 2015; 
Bakkali et al., 2008; Wagner, Elmadfa, 2003). Carvone 
and related metabolites are monoterpene constituents of 
essential oils that presented interesting activities including 
antibacterial, antifungal, anticonvulsivant and cytotoxic to 
cancer cell lines (Carvalho, Fonseca, 2006; Chen et al., 
2006; Freire; Costa, 2006; Stammati et al., 1999). 
The enantiomers (4S)-(+)-carvone and (4R)-(-)-
carvone (Figures 1a and 1b) are monoterpenes found in 
essential oils from various plant species, commonly used 
in food and pharmaceutical products, such as Carum carvi 
L., Anethum graveolens L., Mentha spicata L. and Mentha 
viridis (L.) L. The carvone isomers or essential oils rich in 
carvone were effective against a wide spectrum of human 
I.J. Moro, G. D. G. A. Gondo, E. G. Pierri, R. C. L. R. Pietro, C. P. Soares, D. P. Sousa, A. G. dos Santos
Braz. J. Pharm. Sci. 2017;53(4):e00076Page 2 / 8
pathogenic fungi (eg. Candida albicans) and bacteria 
(eg. Campylobacter jejuni and Listeria monocytogenes) 
(Carvalho, Fonseca, 2006; Mcgeady, Wansley, Logan, 
2002; Rault et al., 2013). Zheng, Kenney and Lam (1992) 
demonstrated that carvone induced the detoxifying phase 
II enzyme glutathione S-transferase in several mouse target 
tissues, which shows the potential cancer chemopreventive 
action of the compound. Moreover, carvone inhibited 
viability and proliferation of Hep-2 cells (human 
carcinoma epithelial cells) probably inducing apoptosis 
without causing DNA damage (Stammati et al., 1999). 
De Sousa et al. (2007a) also demonstrated its depressant 
effects on central nervous system and the anticonvulsivant 
action of (+)-carvone. The monoterpene α,β-epoxycarvone 
(Figure 1c) is an essential oils found in Carum carvi L. 
(Iacobillis et al., 2005), Catasetum maculatum Kunth. 
(Lindquist et al., 1985), Kaempferia galanga L. (Jirovetz 
et al., 2001) and other aromatic plants (Kaiser, 1997). 
This monoterpene presented antimicrobial activity against 
Candida albicans and Staphylococcus aureus (Arruda 
et al., 2006). Additionally, it showed anticonvulsant, 
antinociceptive, anti-inflammatory, antiulcerogenic and 
antioxidant activities (De Sousa et al., 2007b; De Almeida 
et al, 2008; Siqueira et al., 2012; Salgado et al., 2015). The 
semisynthetic compounds (+)-hydroxydihydrocarvone 
and (-)-hydroxydihydrocarvone (Figure 1d and 1e) were 
obtained from hydration of (+)-carvone or (-)-carvone. The 
(-)-Hydroxydihydrocarvone demonstrated antinociceptive 
and anti-inflammatory activities along with depressant 
effects on central nervous system (De Sousa, Oliveira, 
Almeida, 2006; De Sousa et al., 2010; Oliveira et al., 2007; 
Oliveira et al., 2009). Regarding toxicological studies, 
data from literature indicates low toxicity of all these 
compounds (De Sousa et al., 2007a; De Sousa et al., 2007b; 
Oliveira et al., 2009); only (+)-hydroxydihydrocarvone 
have not been evaluated regarding its toxicological 
parameters.
Considering the reported activities of carvone in the 
literature, this study aimed to evaluate the antimicrobial, 
cytotoxic and chemopreventive activities of (+)- and 
(-)-carvone, (+)- and (-)-hydroxydihydrocarvone and 
α,β-epoxycarvone. Although enantiomers have similar 
physicochemical properties, they have different behavior 
in chiral environments, such as endogenous drug receptors, 
membrane proteins and enzymes. The antifungal activity 
was evaluated against Candida parapsilosis, Candida 
tropicalis, Candida krusei and Candida albicans and 
the antimicrobial activity against Escherichia coli 
and Staphylococcus aureus. The cytotoxicity assays 
were performed with human cancer cell lines HepG-2 
(hepatocellular carcinoma) and SiHa (cervical tumor cell) 
and normal strain MRC-5 (normal lung fibroblast) through 
sulphor rodamine B assay. 
Regarding potential chemopreventive action, 
the compounds were also evaluated in the induction 
of quinone reductase assay. Cancer quimioprevention 
involves the use of natural or synthetic agents to prevent, 
reverse or retard the carcinogenesis process. 
MATERIAL AND METHODS
Compounds
(4S)-(+)-carvone and (4R)-(-)-carvone (C- and 
C+) were purchased from Sigma-Aldrich®. Derivatives 
(+)-hydroxydihydrocarvone and (-)-hydroxy dihydro-
carvone (HC+ and HC-) were obtained from hydration of 
C+ and C- according to the method described by Bucho e 
Wuest (1979). The hydration was performed by reaction 
with 50% sulfuric acid, agitating in a magnetic stirrer for 
40 h at room temperature. α,β-Epoxy-carvone (EP) was 
prepared from C- according to Klein and Ohloff (1963).
Preparation of test samples
For antimicrobial testing the substances C+, C-, 
H+, H- and EP were solubilized (10.0 mg/mL) in Tween 
80 (1 % in PBS). Carvones were tested at concentrations 
of 2.5, 1.25, 0.625, 0.312, 0.156, 0.078, 0.039 and 0.019 
FIGURE 1 - Chemical structures of (a) (4S)-(+)-carvone, 
(b) (4R)-(-)-carvone, (c) α,β-epoxycarvone, (d) (-)-hydroxy-
dihydrocarvone and (e) (+)-hydroxydihydrocarvone.
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mg/mL. In the cytotoxicity and quinone reductase assays 
the concentrations of carvones were 50.0, 16.6, 5.5, 1.8 
and 0.6 μg/mL.
Microorganisms
Strains of bacteria and yeast used in this study were 
Bacillus subtilis (ATCC 9362), Staphylococcus aureus 
(ATCC 25923), Escherichia coli (ATCC 10536), Candida 
albicans (ATCC 64548), Candida parapsilosis (ATCC 
22019), Candida tropicalis (ATCC 750), and Candida 
krusei (ATCC 6258).  A bacterial colony of each strain 
was inoculated in brain heart infusion (BHI) broth and 
incubated at 37 °C for 24 h. The final concentration of 
cells in suspension was adjusted to 0.5 McFarland standard 
(approximately 1.5 x 108 cells/mL). Yeast colonies were 
incubated for 48 h at 35 °C and suspended in 5 mL of 
0.9% sterile saline solution. Yeast cells were counted in 
Neubauer chamber and adjusted to a final concentration 
of 2.5 – 5.0 x 103 cells/mL.
Positive controls
Ampicillin was used as positive control in 
antibacterial assays with stock solution concentration of 
50 mg/mL (deionized water). Amphotericin B was used as 
a positive control for Candida strains with stock solution 
concentration of 32 mg/mL (dimethylsulfoxide: RPMI-
1640 medium 1:5; v/v).
Determination of Minimum Inhibitory 
Concentration (MIC) by microplate dilution 
Method and Minimum Fungicidal Concentration 
(MFC)
MIC was determined using microplate dilution 
assays according to reference document M27-A3 of the 
CLSI with modifications (CLSI, 2008). RPMI-1640 
containing glutamine and phenol red was used in Candida 
strains maintenance, the medium, without sodium 
bicarbonate, was supplemented with 3-(N-morphin)-
propanesulfonic acid (MOPS) at 0.165 M, pH 7.0. In each 
well of a microplate, 100 μL of sterilized RPMI-1640 
medium was added. Then, 100 μL of carvone samples 
were added to the first well of each column (columns 1-8). 
In the column 9, 100 μL of amphotericin B was added to 
the first well. Serial dilution was performed by transferring 
100 μL from the first to the next until the end of the line. 
Finally, 100 μL of yeast was added to each well to a final 
concentration of 2.5 x 103 cells/mL. Controls: yeast growth 
control (medium and yeast), solvent control (100 μL of 1% 
Tween 80 with and without yeast), sterility control (only 
medium), compound control (compound and medium) 
and positive control (amphotericin B). The microplates 
were incubated for 48 h at 35 °C under agitation. Fungal 
growth inhibition was assessed by the addition of 20 
μL of 2% aqueous solution 2,3,5-triphenyltetrazolium 
chloride (TTC) that was read after incubation at 35 
°C for 1 h. The lowest concentration which no visible 
growth was observed was considered the minimum 
inhibitory concentration (MIC). Tests were performed in 
triplicate. The minimal fungicidal concentration (MFC) 
was determined by plating the contents of each sample 
from MIC test into Petri dish containing Saboraund agar. 
The plates were incubated for 48 h at 35 °C. MFC was 
evaluated by absence or presence of yeast growth.
Determination of Minimum Inhibitory 
Concentration (MIC) by microplate dilution 
method and Minimum Bactericidal Concentration 
(MBC)
MIC was determined using dilution microplate 
method, according to reference document M7-A9 of the 
CLSI with modifications (CLSI, 2012). For that, 100 μL 
of BHI (brain heart infusion) was added to the wells. Then, 
100 μL of carvone (or derivatives) sample was added to 
the first well of each column (columns 1-8). In the column 
9, 100 μL of ampicillin was added in the first well. Serial 
dilution was performed transferring 100 μL from the first 
well to the subsequent until the end of each line. Finally, 
100 μL of bacterial suspension (1:200; BHI) was added to 
each well. The final concentration of bacteria in each well 
was 2.5 x 105 cells/mL. Controls: solvent control (Tween 
80 1% with and without bacteria), growth control (bacteria 
and medium), sterility control (only medium), compound 
control (compound and medium) and positive control 
(ampicillin). Microplates were incubated for 24 h at 37 
°C. The growth inhibition was detected by adding 20 μL 
of a 0.01% aqueous solution of resazurin after incubation 
at 37 °C for 1 h. Tests were performed in triplicate. 
The minimal bactericidal concentration (MBC) was 
determined by plating each sample of the MIC test into 
Petri dishes containing agar Mueller-Hinton. Petri dishes 
were incubated for 24 h at 37 °C. MBC was evaluated by 
absence or presence of bacterial growth.
Cell lines and cell culture
The cell lines used in cytotoxicity assays was 
HepG2 (human hepatocellular l iver carcinoma, 
ATCC®HB-8065™), courtesy of Dra. Dayse Maria 
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Favero Salvadori (Department of Patology, UNESP), 
SiHa (human cancer of cervix, ATCC®HB-35™), 
courtesy of Dra. Luisa Lina Villa (Laboratory of Virology, 
Ludwig Institute) and MRC-5 (human lung fibroblast, 
ATCC®CCL-171™). In the quinone-reductase assay, 
the cell line used was Hepa c1c7 (murine hepatocellular 
carcinoma, ATCC®CRC-2026™), courtesy of Dr. John 
M. Pezzuto of College of Pharmacy, University of Hawaii. 
The medium used for in vitro culture of HepG2, SiHa 
and MRC-5 was Dulbecco´s Modified Eagle Medium 
(DMEM) and for Hepa c1c7 was Alfa Modification 
of Eagle Medium (α-MEM). DMEM and α-MEM 
were supplemented with fetal bovine serum for cells 
maintenance. The cells were cultured in bottles at 5% CO2 
atmosphere and 37 °C until the cell monolayer reached 
confluence (80%). After, cells were washed with Hanks 
and trypsin-EDTA solutions to detach cells and counting. 
Sulforhodamine B (SRB) assay
SRB is used to measure the protein content in 
adherent cell cultures using 96 wells microplate. The 
plates were pre-incubated with culture medium (DMEM 
supplemented with 10% fetal bovine serum, 100 μL/well) 
for 24 h at 37 °C in incubator with 5% CO2. Wells without 
cells were used as controls, doxorrubicine as positive 
control (36.79 μM) and dimethyl sulfoxide (DMSO 1%) 
as vehicle control. After 24 h of incubation cells adhesion 
and growth were observed. Then, the medium was 
discarded and treatments, controls and DMEM without 
fetal bovine serum were added in each well. After 24 h 
of incubation, the cells were fixed with trichloroacetic 
acid (100 μL/well) and placed under refrigeration for 1 
h at 4 °C. TCA was removed and plates were washed 
in low-flow of water three times and dried. Following, 
plates were stained for 20 min at room temperature with 
SRB 0.4% (50 μL/well). In mildly acidic conditions the 
colorant binds to basic amino acid residues in fixed cells. 
This reaction provides an estimate of the total protein 
mass. The plates were washed with 1% acetic acid solution 
and dried at room temperature. The unbound dye was 
removed after washing, the dyestuff bound to the protein 
was solubilized in a basic medium (Tris base, 10 mM, pH 
10.5) to determine the optical density in a plate reader at 
570 nm. The colorimetric evaluation gives an estimate of 
total protein mass. The assay was conducted as described 
in Skehan et al. (1990) with modifications (Voigt, 2005). 
Cellular concentration used was 1.4 x 104 cells/mL. 
We calculated the average absorbance of the 
negative control (MAbsNC) and vehicle (MabsVC), for 
each concentration of the tested substances (MabsT) and 
positive control (MabsPC). The percentage of living cells 
was given by: 
% survival = [(MAbsT – MAbsNC)/(MAbsVC – MAbsNC)] x 100
 
Induction of quinone reductase assay
To evaluate the carvones as inducers of quinone 
reductase, 104 cells/mL of mouse Hepac1c7 cells were 
seeded in two sterile 96 wells microplates. In one 
plate (Plate 1), the cytotoxicity assay was carried out 
using crystal violet dye and in a second plate (Plate 2), 
the quinone reductase assay (NQO1) was performed. 
After 24 h of pre-incubation, the medium was replaced 
by 190 μL of fresh culture medium and 10 μL of test 
compounds, 4´-bromoflavone (0.01 μM) or DMSO 
(vehicle control). NQO1 activity was assessed after 48 h 
of cell exposure using 3-(4,5-dime-tylthiazo-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction to blue 
formazan based on NADPH-dependent menadiol system. 
Plate 1: after 48 h, the medium was removed and 100 μL 
of 0.2% crystal violet solution in 2 % ethanol was added. 
Subsequently, 200 μL of SDS 0.5% in 50% ethanol were 
added. The absorbance was determined in a microplate 
reader at 590 nm (Power Wave 200 Microplate Scanning, 
Bio-Tek Instrument®). Plate 2: medium was removed and 
50 μL of 0.8% solution of digitonin in 2 mM EDTA (pH 
7.8) was added. The plate was incubated at 37° C for 10 
min (mild agitation). Finally, 200 μL of the following 
reactional mixture was added to the wells: water – 28 mL; 
Tris-HCl (0.5 M, pH 7.4) – 1.5 mL; tween 20 (1,5 %) 
– 0.2 mL; FAD (7.5 mM) – 20 μL; glucose-6-phosphate 
(150 mM) – 0.2 mL; NADP (50 mM) – 18.0 μL; albumin 
bovine serum – 20 mg; MTT – 9.0 mg; glucose-6-phosphate 
dehydrogenase – 60 U; menadione (50 mM) – 30 μL. The 
microplate was stirred until the blue color began to appear. 
The plates were placed in spectrophotometer and measured 
at 590 nm (Scanning Microplate Power Wave 200, Bio-Tek 
Instrument®) (Prochaska et al., 1988; Fahey et al., 2004).
NQO1 induction ratio (IR) was represented by 
specific enzyme activity of cells treated compared to 
control (DMSO 0.5%). Compounds were considered 
active if IR > 2.0. 4’-bromoflavone, a potent NQO1 
inducer, was used as positive control for the assay.
Statistical analysis
One-way analysis of variance (ANOVA) with 
Tukey´s post-test was employed for the statistical analysis 
for cytotoxicity and chemoprevention results. Data were 
expressed as the mean ± SD. 
Evaluation of antimicrobial, cytotoxic and chemopreventive activities of carvone and its derivatives
Braz. J. Pharm. Sci. 2017;53(4):e00076 Page 5 / 8
RESULTS AND DISCUSSION
Antimicrobial assays
Compounds C- and HC- only presented antibacterial 
activity against S. aureus at the highest concentration 
(MIC/MBC: 2.5 mg/mL) (Table 1). C+, HC+ and EP 
did not show antibacterial activity. Data from literature 
showed activity of EP against S. aureus using a diffusion 
method in plates with solid medium (Arruda et al., 2006). 
Also from literature, C- and C+ inhibited the growth of 
E. coli at concentrations of 9.6 mg/mL (Naigre et al., 
1996) and 1.5 mg/mL (MIC) (Helander et al., 1998), 
respectively. All these literature data differ from results 
found in our study. 
Table I shows the results of MIC for antifungal 
activity and MFC. Carvones presented weak activity 
against C. tropicalis with values of MIC/MFC of 2.5 
mg/mL and low inhibitory action against C. parapsilosis 
was also observed (MFC: 1.25 mg/mL). C+ presented 
intermediate activity to C. Krusei (0.625 mg/mL). 
Carvones presented activity against C. albicans in this 
study, C+ and C- were the most active compounds with 
MIC/MFC values of 0.312 and 0.625 mg/mL, respectively. 
Scientific literature reports that essential oils rich in 
C+ inhibited the growth of this fungus (Jirovetz et al., 
2003) and that carvone inhibited the transformation of 
C. albicans to its pathogenic form (Mcgeady, Wansley, 
Logan, 2002). Similarly to carvone and its derivatives, 
several monoterpenes also showed activity against C. 
albicans, including linalool, citral, citronellol, thymol, 
eugenol and carvacrol (Zore et al., 2001; Alvarez et al., 
2012). All samples inhibited C. krusei and EP and C+ 
were the most active compounds against this yeast (MIC/
MFC: 0.625 mg/mL).
Cytotoxicity assay
All samples presented low cytotoxicity in the cell 
lines tested at the concentrations of 0.62 to 50.00 μg/mL 
and did not reach IC50 or IC20 values (Figure 2). In vitro 
assays have been used to evaluate toxicity, determine 
activity and mechanism of action of natural antitumor 
products (Nagle et al., 2004). Despite carvone and its 
derivatives did not show cytotoxicity in this study, previous 
studies showed cytotoxic activity against prostate and 
breast cancer cell lines, P-815 (murine mastocytoma), 
K-562 (human chronic myeloid leukemia), CEM (acute 
lymphoblastoid leukemia T) and MCF-7 (human breast 
adenocarcinoma) (Stammati et al., 1999; Chen et al., 2006; 
Jaafari et al., 2012). Natural carvones are present in low 
concentrations in food and have applications in industry 
and agriculture, increasing the human exposure to these 
compounds (Carvalho, Fonseca, 2006). The low toxicity 
observed in this study suggests safety in the use of carvones.
Quinone reductase assay
Three independent experiments were performed 
to evaluate the carvone and derivatives ability to induce 
quinone reductase enzyme. The cell strain used was Hepa 
c1c7 and 4’-bromoflavone was used as positive control. 
Carvones did not show induction of quinone reductase at 
tested concentrations (Figure 3). The percentage of living 
cells by crystal violet assay also demonstrated that these 
compounds did not present cytotoxic activity. 
CONCLUSIONS
Plants’ secondary metabolites are an important 
source to development of new drugs. This study evaluated 
TABLE I - Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of carvones 
against S. aureus and E. coli
Compounds




(mg/mL) MIC MFC MIC MFC MIC MFC MIC MFC
C+ > 2.500 >2.500 1.250 1.250 2.500 2.500 0.625 0.625 0.312 0.312
C- >2.500 2.500 - - 2.500 2.500 1.250 1.250 0.625 0.625
HC+ >2.500 >2.500 1.250 1.250 2.500 2.500 1.250 1.250 1.250 1.250
HC- >2.500 2.500 1.250 1.250 2.500 2.500 2.500 2.500 1.250 1.250
EP >2.500 >2.500 0.625 1.250 2.500 2.500 0.625 0.625 1.250 1.250
Ampicillin 3,91±1,56 31,25
Amphotericin B 0.500 2.000 0.100 4.000 1.000 4.000 0.500 2.000
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the activity of carvone and its derivatives against strains of 
bacteria and fungi, the cytotoxicity in human cells and the 
inhibition of quinone reductase in murine carcinoma cells. 
As conclusions, C- and HC- showed low activity against E. 
coli. However, EP, C+ and HC+ did not inhibit the growth 
of the bacteria strains tested. Compounds presented weak 
antifungal activity against C. tropicalis and C. parapsilosis. 
EP and C+ showed moderate activity against C. krusei 
similar to C+ and C- against C. albicans. All tested samples 
demonstrated fungistatic and fungicidal activity against 
FIGURE 2 - Determination of cell viability (%) in HepG2, SiHa and MRC-5 for (4S)-(+)-carvone and (4R)-(-)-carvone (C- and 
C+), (+)-hydroxydihydrocarvone and (-)-hydroxydihydrocarvone (HC+ and HC-) and α,β-epoxy-carvone (EP); three independent 
experiments (mean ± standard deviation). PC: positive control; VC: vehicle control. Statistical analysis: One-way ANOVA, post-
test Tukey. P < 0.001.
FIGURE 3 - (A)-induced enzyme QR (mean ±standard deviation) in Hepa c1c7. Positive control: BNF. (B)-cell viability (%) 
evaluated by crystal violet assay after treatment during 48 h. Statistical analysis: oneway ANOVA, post-test Tukey.
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Candida yeasts and the most significant result was found 
with C+, C- and EP. These results suggest the potential use 
of carvones and its derivatives as antifungal agents against 
Candida yeasts. In citotoxicity SRB assay none of the 
compounds showed activity in HepG2, SiHa and MRC-
5 cell lines and also did not inhibit the enzyme quinone 
reductase. The absence of cytotoxicity in both cancer and 
normal cell lines indicates the safe use of these compounds.
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